IS5537A - Meðferðarvirk blanda til að gefa tolteródín með stýrðri losun - Google Patents
Meðferðarvirk blanda til að gefa tolteródín með stýrðri losunInfo
- Publication number
- IS5537A IS5537A IS5537A IS5537A IS5537A IS 5537 A IS5537 A IS 5537A IS 5537 A IS5537 A IS 5537A IS 5537 A IS5537 A IS 5537A IS 5537 A IS5537 A IS 5537A
- Authority
- IS
- Iceland
- Prior art keywords
- tolterodine
- administer
- controlled release
- therapeutic formulation
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802864A SE9802864D0 (sv) | 1998-08-27 | 1998-08-27 | Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder |
SE9803871A SE9803871D0 (sv) | 1998-11-11 | 1998-11-11 | Therapeutic method and formulation |
PCT/SE1999/001463 WO2000012069A1 (en) | 1998-08-27 | 1999-08-26 | Therapeutic formulation for administering tolterodine with controlled release |
Publications (2)
Publication Number | Publication Date |
---|---|
IS5537A true IS5537A (is) | 2000-06-15 |
IS2976B IS2976B (is) | 2017-07-15 |
Family
ID=26663376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5537A IS2976B (is) | 1998-08-27 | 2000-06-15 | Lyfjablanda til inntöku um munn sem inniheldur tolteródín og hefur stýrða losun |
Country Status (31)
Country | Link |
---|---|
US (1) | US6770295B1 (is) |
EP (2) | EP2153825A1 (is) |
CN (1) | CN1239152C (is) |
AP (1) | AP1529A (is) |
AR (1) | AR029311A1 (is) |
AT (1) | ATE487471T1 (is) |
AU (1) | AU745190B2 (is) |
BG (1) | BG65168B1 (is) |
CA (1) | CA2311755C (is) |
CY (1) | CY1111088T1 (is) |
CZ (1) | CZ302630B6 (is) |
DE (1) | DE69942928D1 (is) |
DK (1) | DK1039882T3 (is) |
EA (1) | EA002720B1 (is) |
GE (1) | GEP20043354B (is) |
HK (1) | HK1034664A1 (is) |
HU (1) | HUP0100437A3 (is) |
ID (1) | ID25824A (is) |
IL (1) | IL136294A (is) |
IS (1) | IS2976B (is) |
ME (1) | ME00850B (is) |
MY (1) | MY127946A (is) |
NO (1) | NO329830B1 (is) |
NZ (1) | NZ504618A (is) |
OA (1) | OA11636A (is) |
PT (1) | PT1039882E (is) |
SI (1) | SI1039882T1 (is) |
SK (1) | SK287111B6 (is) |
TR (1) | TR200001998T1 (is) |
UA (1) | UA72882C2 (is) |
WO (1) | WO2000012069A1 (is) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0957073A1 (en) * | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
DE19922662C1 (de) * | 1999-05-18 | 2000-12-28 | Sanol Arznei Schwarz Gmbh | Transdermales therapeutisches System (TTS) Tolterodin enthaltend |
DE19932651A1 (de) * | 1999-07-13 | 2001-01-18 | Hexal Ag | Transdermales therapeutisches System zur Anwendung von Tolterodin |
SK6412002A3 (en) * | 1999-11-11 | 2002-09-10 | Pharmacia Ab | Pharmaceutical formulation containing tolterodine and its use |
DE10149674A1 (de) | 2001-10-09 | 2003-04-24 | Apogepha Arzneimittel Gmbh | Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung |
US8329217B2 (en) | 2001-11-06 | 2012-12-11 | Osmotica Kereskedelmi Es Szolgaltato Kft | Dual controlled release dosage form |
US20030185882A1 (en) | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
WO2003039524A1 (en) * | 2001-11-09 | 2003-05-15 | Pharmacia Ab | Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
US6773421B2 (en) | 2001-12-14 | 2004-08-10 | Kimberly-Clark Worlwide, Inc. | Combination for managing the involuntary loss of bladder control |
EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
DE60332387D1 (de) * | 2002-12-13 | 2010-06-10 | Warner Lambert Co | Alpha-2-delta-ligand zur behandlung vonsymptomen der unteren harnwege |
CA2514022C (en) * | 2003-01-22 | 2010-07-13 | Pfizer Health Ab | Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders |
DE10315917A1 (de) * | 2003-04-08 | 2004-11-18 | Schwarz Pharma Ag | Hochreine Basen von 3,3-Diphenylpropylaminmonoestern |
EP1635795A1 (en) * | 2003-05-30 | 2006-03-22 | Ranbaxy Laboratories, Ltd. | Controlled release pharmaceutical compositions of tolterodine and processes for their preparation |
US7410978B2 (en) | 2003-11-04 | 2008-08-12 | Supernus Pharmaceuticals, Inc. | Once daily dosage forms of trospium |
JP4771956B2 (ja) | 2003-11-04 | 2011-09-14 | スパーナス ファーマシューティカルズ インコーポレイテッド | バイオアベイラビリティーエンハンサを含む第四級アンモニウム化合物の組成物 |
WO2005105036A1 (en) * | 2004-04-28 | 2005-11-10 | Natco Pharma Limited | Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation |
EP1629834A1 (en) * | 2004-08-27 | 2006-03-01 | KRKA, D.D., Novo Mesto | Sustained release pharmaceutical composition of tolterodine |
US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
CA2604052C (en) * | 2005-04-06 | 2014-07-08 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of cns-related conditions |
CN1330297C (zh) * | 2005-07-04 | 2007-08-08 | 宛六一 | 酒石酸托特罗定软胶囊及其制备方法 |
KR20070012205A (ko) * | 2005-07-22 | 2007-01-25 | 주식회사종근당 | 경시 안정성을 갖는 톨테로딘을 함유하는 제어방출형 펠렛 |
JP5869745B2 (ja) | 2006-02-03 | 2016-02-24 | プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー | 25−ヒドロキシビタミンd2及び25−ヒドロキシビタミンd3によるビタミンd不足及び欠乏の治療 |
US20070248670A1 (en) * | 2006-04-21 | 2007-10-25 | Van Den Heuvel Dennie J M | Tolterodine beads |
EP3659608A1 (en) | 2006-06-21 | 2020-06-03 | Opko Ireland Global Holdings, Ltd. | Therapy using vitamin d repletion agent and vitamin d hormone replacement agent |
CN104257667B (zh) | 2007-04-25 | 2019-06-04 | 欧普科Ip 控股Ii 有限公司 | 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物 |
ES2956794T3 (es) | 2007-04-25 | 2023-12-28 | Eirgen Pharma Ltd | Liberación controlada de 25-hidroxivitamina D |
EP3335712A1 (en) | 2007-04-25 | 2018-06-20 | Opko Renal, LLC | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
EP2173329A1 (en) * | 2007-07-03 | 2010-04-14 | Synthon B.V. | Tolterodine bead |
US8486452B2 (en) * | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
US8871275B2 (en) | 2007-08-08 | 2014-10-28 | Inventia Healthcare Private Limited | Extended release compositions comprising tolterodine |
US20090192228A1 (en) * | 2008-01-28 | 2009-07-30 | Actavis Group Ptc Ehf | Controlled-Release Tolterodine Compositions and Methods |
US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
CN102046812A (zh) | 2008-04-02 | 2011-05-04 | 赛特克罗公司 | 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒 |
TWI630208B (zh) | 2008-12-08 | 2018-07-21 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
KR101004205B1 (ko) | 2008-12-17 | 2010-12-24 | 동아제약주식회사 | 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물 |
WO2011095388A1 (en) | 2010-02-04 | 2011-08-11 | Synthon Bv | Tolterodine bead |
KR101746204B1 (ko) * | 2010-02-18 | 2017-06-13 | 에스케이케미칼주식회사 | 피부 투과가 개선된 톨테로딘의 경피 투여용 조성물 |
KR102125424B1 (ko) | 2010-03-29 | 2020-06-22 | 사이토크로마 인코포레이티드 | 부갑상선 수준을 낮추기 위한 방법 및 조성물 |
WO2011137054A1 (en) | 2010-04-30 | 2011-11-03 | Merck Sharp & Dohme Corp. | Novel beta 3 adrenergic receptor agonists |
DE102010024105A1 (de) * | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermale Verabreichung von Memantin |
US20130195957A1 (en) * | 2010-08-03 | 2013-08-01 | Hisamitsu Pharmaceutical Co., Inc. | Patch and method for enhancing adhesion force of the same |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
SG10201911274TA (en) | 2014-08-07 | 2020-02-27 | Opko Ireland Global Holdings Ltd | Adjunctive therapy with 25-hydroxyvitamin d |
BR112018069727A2 (pt) | 2016-03-28 | 2019-02-05 | Opko Ireland Global Holdings Ltd | métodos de tratamento com vitamina d |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598123A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
SE8800207D0 (sv) | 1988-01-22 | 1988-01-22 | Kabivitrum Ab | Nya aminer, deras anvendning och framstellning |
US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
WO1993023025A1 (en) * | 1992-05-13 | 1993-11-25 | Alza Corporation | Transdermal administration of oxybutynin |
SE9203318D0 (sv) | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
TW344661B (en) * | 1993-11-24 | 1998-11-11 | Lilly Co Eli | Pharmaceutical composition for treatment of incontinence |
AU7994694A (en) * | 1994-10-21 | 1996-05-15 | Leiras Oy | Controlled release oral delivery system containing oxybutynin |
US5677346A (en) * | 1995-01-31 | 1997-10-14 | Sepracor, Inc. | Treating urinary incontinence using (S)-desethyloxybutynin |
JP2000515525A (ja) * | 1996-07-19 | 2000-11-21 | アベーグ,グンナー | 尿と胃腸の疾患の治療におけるs(―)―トルテロジン |
EP0927034A1 (en) * | 1996-09-19 | 1999-07-07 | American Home Products Corporation | Method of treating urinary incontinence |
-
1999
- 1999-08-26 PT PT99946521T patent/PT1039882E/pt unknown
- 1999-08-26 EP EP09173927A patent/EP2153825A1/en not_active Withdrawn
- 1999-08-26 TR TR2000/01998T patent/TR200001998T1/xx unknown
- 1999-08-26 OA OA1200000309A patent/OA11636A/en unknown
- 1999-08-26 EA EA200000468A patent/EA002720B1/ru not_active IP Right Cessation
- 1999-08-26 WO PCT/SE1999/001463 patent/WO2000012069A1/en active Application Filing
- 1999-08-26 CZ CZ20001924A patent/CZ302630B6/cs not_active IP Right Cessation
- 1999-08-26 HU HU0100437A patent/HUP0100437A3/hu unknown
- 1999-08-26 SI SI9931050T patent/SI1039882T1/sl unknown
- 1999-08-26 DK DK99946521.4T patent/DK1039882T3/da active
- 1999-08-26 NZ NZ504618A patent/NZ504618A/xx not_active IP Right Cessation
- 1999-08-26 US US09/582,498 patent/US6770295B1/en not_active Expired - Lifetime
- 1999-08-26 CA CA2311755A patent/CA2311755C/en not_active Expired - Lifetime
- 1999-08-26 MY MYPI99003665A patent/MY127946A/en unknown
- 1999-08-26 CN CNB99801916XA patent/CN1239152C/zh not_active Expired - Lifetime
- 1999-08-26 AT AT99946521T patent/ATE487471T1/de active
- 1999-08-26 AR ARP990104280A patent/AR029311A1/es not_active Application Discontinuation
- 1999-08-26 GE GE3951A patent/GEP20043354B/en unknown
- 1999-08-26 UA UA2000052950A patent/UA72882C2/uk unknown
- 1999-08-26 IL IL13629499A patent/IL136294A/en unknown
- 1999-08-26 AP APAP/P/2000/001823A patent/AP1529A/en active
- 1999-08-26 ME MEP-2001-331A patent/ME00850B/me unknown
- 1999-08-26 AU AU58918/99A patent/AU745190B2/en not_active Expired
- 1999-08-26 EP EP99946521A patent/EP1039882B1/en not_active Revoked
- 1999-08-26 SK SK749-2000A patent/SK287111B6/sk not_active IP Right Cessation
- 1999-08-26 DE DE69942928T patent/DE69942928D1/de not_active Expired - Lifetime
- 1999-08-26 ID IDP20001006A patent/ID25824A/id unknown
-
2000
- 2000-05-26 BG BG104476A patent/BG65168B1/bg unknown
- 2000-06-09 NO NO20002977A patent/NO329830B1/no not_active IP Right Cessation
- 2000-06-15 IS IS5537A patent/IS2976B/is unknown
-
2001
- 2001-07-12 HK HK01104868A patent/HK1034664A1/xx not_active IP Right Cessation
-
2010
- 2010-11-17 CY CY20101101027T patent/CY1111088T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS5537A (is) | Meðferðarvirk blanda til að gefa tolteródín með stýrðri losun | |
NO993484D0 (no) | Farmasoeytisk preparat med regulert frigjoeringsvirkning | |
DE69829254D1 (de) | Arzneistoffzubereitung mit kontrollierter Wirkstofffreisetzungsrate | |
DK1208864T4 (da) | Forbedringer til lægemiddelafgivelsesindretninger | |
ID20837A (id) | Mikrokapsul dengan laju pelepasan yang mudah disesuaikan | |
ATE308319T1 (de) | Dosierungsform mit verlängerter wirkstoffabgabe | |
EE200000595A (et) | Toimeaine viimine kandjamaatriksisse | |
EP1014942A4 (en) | NON-STEROID ANTI-INFLAMMATORY COMPOSITIONS OF MEDICAMENTS FOR LOCAL USE ON THE SKIN | |
DE69938295D1 (de) | Kleinlumiges biologisches transplantat mit therapeutischer verabreichungsvorrichtung | |
DK2052714T3 (da) | Topisk gel-fremføringssystem til behandling af hudlidelser | |
ID22878A (id) | Komposisi aktif secara terapi | |
DE69925639D1 (de) | Glicazidhaltige matrixtablette mit verzögerter wirkstoffverabreichung zur oralen anwendung | |
ATE257694T1 (de) | Expandierbares gastroretentives therapie-system mit verlängerter magenverweildauer | |
NO20001375D0 (no) | Legemiddelformulering med kontrollert virkestoffrigivning | |
DK1028718T3 (da) | Formulering med opretholdt frigivelse indeholdende venlafaxin | |
DK0936902T3 (da) | Spraytørrede mikropartikler som terapeutiske bærere til anvendelse i terapi | |
IL134075A0 (en) | Analgesic with controlled active substance release | |
PT1087660E (pt) | Formulacoes para repelir vermina | |
DE60001266D1 (de) | Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung | |
NO993435D0 (no) | Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon | |
ES1041098Y (es) | Dispositivo electrovibrador que se coloca en cunas para niños con la finalidad de conciliar el sueño. | |
ID17052A (id) | Turunan-turunan asam asetat terapeutik | |
EE200000018A (et) | 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine | |
NO971879D0 (no) | Preparat for transdermal administrasjon | |
AR016434A1 (es) | Procedimiento para preparar clorobenzoxazoles |